Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Philippines seals biggest COVID-19 vaccine order yet, for 40 mln Pfizer doses

Sun, 20th Jun 2021 16:45

* Deliveries to begin in late September

* Philippines has secured 113 mln doses from vaccine
suppliers

* Government wants to vaccinate up to 70 million Filipinos
(Updates with Israel medical experts arriving to help boost
vaccine rollout)

MANILA, June 20 (Reuters) - The Philippine government has
signed a supply agreement for 40 million doses of the COVID-19
vaccine developed by Pfizer Inc and BioNTech SE,
in its biggest coronavirus vaccine deal to date.

Deliveries of the vaccine will begin in late September,
Carlito Galvez, head of the government's COVID-19 vaccine
procurement, said on Sunday. It "will significantly boost our
national immunisation programme and will enable us to realise
our goal of achieving herd immunity by year-end," he said.

The Philippines has now ordered 113 million doses from five
vaccine manufacturers, including 26 million from China's Sinovac
, 10 million of Russia's Sputnik V, 20 million doses from
Moderna and 17 million doses from AstraZeneca.

So far, the Philippines has adminstered slightly more than 8
million doses, of which about 6 million were first doses, making
slow progress towards the government's target to vaccinate up to
70 million people this year in a country of 110 million.

The Philippines earlier this month started a programme to
vaccinate 35 million people working outside their homes, while
continuing to inoculate priority sectors such as healthcare
workers and the elderly.

Vaccine supply around the capital Manila remains limited,
while COVID-19 cases in several provinces have surged,
complicating efforts to ramp up the immunisation drive in a
country with some of Asia's largest numbers of infections and
deaths.

The Philippines also expects 44 million doses from the
international COVAX vaccine sharing facility. Orders of 16
million doses of vaccines developed by Novavax and
Johnson & Johnson were still under negotiation, Galvez
said.

The Philippines will allow the Pfizer-BioNTech vaccine to be
given to children aged 12 to 15, possibly starting later this
year, he said.

To help boost the government's COVID-19 response, a team of
medical experts from the Israel Ministry of Health has arrived
in Manila. Israel has been a world leader in rolling out
vaccines, having successfully reduced its active COVID-19 cases
and gradually reopened its economy. Most of its population has
received the Pfizer-BioNTech vaccine.

Galvez said the health experts will share strategies,
including how to address vaccine hesitancy.
(Reporting by Enrico Dela Cruz; Editing by William Mallard and
Christopher Cushing)

More News
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.